Biotechnology Lumos Pharma Announces that the USPTO Has Granted Patent Protection for Novel Formulation of LUM-201, Extending Exclusivity to 2042 – Lumos Pharma (NASDAQ:LUMO) Read more
Biotechnology Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update – Lumos Pharma (NASDAQ:LUMO) Read more
Biotechnology Lumos Pharma to Participate in Oppenheimer’s 34th Annual Healthcare Life Sciences Conference – Lumos Pharma (NASDAQ:LUMO) Read more